Hyperoxia-induced signal transduction pathways in pulmonary epithelial cells

Free Radical Biology and Medicine

Volumn 42, Issue 7, 2007, Pages 897-908

  Zaher, Tahereh E ^a,b   Miller, Edmund J ^b   Morrow, Dympna M P ^b   Javdan, Mohammad ^b   Mantell, Lin L ^a,b  

^a ST JOHN'S UNIVERSITY   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

Epithelial cells; Hyperoxia; Lung injury; MAPK; NF B; ROS; Signal transduction

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 11; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; STAT PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NF E2; TUMOR NECROSIS FACTOR;

ACUTE LUNG INJURY; ARTIFICIAL VENTILATION; CELL DEATH; GENE EXPRESSION REGULATION; HUMAN; HYPEROXIA; IMMUNE RESPONSE; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; LUNG INJURY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL DEATH; CYTOKINES; EPITHELIAL CELLS; GENE EXPRESSION; HUMANS; HYPEROXIA; LUNG; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 33847626306     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.01.021     Document Type: Review

References (151)

1. Seta K.A., Yuan Y., Spicer Z., Lu G., Bedard J., Ferguson T.K., Pathrose P., Cole-Strauss A., Kaufhold A., and Millhorn D.E. The role of calcium in hypoxia-induced signal transduction and gene expression. Cell Calcium 36 (2004) 331-340
2. Snider G.L., and Rinaldo J.E. Oxygen therapy, oxygen therapy in medical patients hospitalized outside of the intensive care unit. Am. Rev. Respir. Dis. 122 (1980) 29-36
3. Wispe J.R., and Roberts R.J. Molecular basis of pulmonary oxygen toxicity. Clin. Perinatol. 14 (1987) 651-666
4. Northway Jr. W.H., Rosan R.C., and Porter D.Y. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N. Engl. J. Med. 276 (1967) 357-368
5. Slutsky A.S. Lung injury caused by mechanical ventilation. Chest 116 (1999) 9S-15S
6. Buccellato L.J., Tso M., Akinci O.I., Chandel N.S., and Budinger G.R. Reactive oxygen species are required for hyperoxia-induced Bax activation and cell death in alveolar epithelial cells. J. Biol. Chem. 279 (2004) 6753-6760
7. Asikainen T.M., and White C.W. Pulmonary antioxidant defenses in the preterm newborn with respiratory distress and bronchopulmonary dysplasia in evolution: implications for antioxidant therapy. Antioxid. Redox Signal. 6 (2004) 155-167
8. Frank L., and Massaro D. Oxygen toxicity. Am. J. Med. 69 (1980) 117-126
9. Tang G., White J.E., Gordon R.J., Lumb P.D., and Tsan M.F. Polyethylene glycol-conjugated superoxide dismutase protects rats against oxygen toxicity. J. Appl. Physiol. 74 (1993) 1425-1431
10. Freeman B.A., and Crapo J.D. Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J. Biol. Chem. 256 (1981) 10986-10992
11. Sanders S.P., Zweier J.L., Kuppusamy P., Harrison S.J., Bassett D.J., Gabrielson E.W., and Sylvester J.T. Hyperoxic sheep pulmonary microvascular endothelial cells generate free radicals via mitochondrial electron transport. J. Clin. Invest. 91 (1993) 46-52
12. Zhang X., Shan P., Sasidhar M., Chupp G.L., Flavell R.A., Choi A.M., and Lee P.J. Reactive oxygen species and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase mediate hyperoxia-induced cell death in lung epithelium. Am. J. Respir. Cell Mol. Biol. 28 (2003) 305-315
13. Parinandi N.L., Kleinberg M.A., Usatyuk P.V., Cummings R.J., Pennathur A., Cardounel A.J., Zweier J.L., Garcia J.G., and Natarajan V. Hyperoxia-induced NAD(P)H oxidase activation and regulation by MAP kinases in human lung endothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 284 (2003) L26-L38
14. Cacciuttolo M.A., Trinh L., Lumpkin J.A., and Rao G. Hyperoxia induces DNA damage in mammalian cells. Free Radic. Biol. Med. 14 (1993) 267-276
15. Mcphail L.C., and Snyderman R. Activation of the respiratory burst enzyme in human polymorphonuclear leukocytes by chemoattractants and other soluble stimuli. Evidence that the same oxidase is activated by different transductional mechanisms. J. Clin. Invest. 72 (1983) 192-200
16. Li Y., Zhang W., Mantell L.L., Kazzaz J.A., Fein A.M., and Horowitz S. Nuclear factor-kappaB is activated by hyperoxia but does not protect from cell death. J. Biol. Chem. 272 (1997) 20646-20649
17. Barazzone C., and White C.W. Mechanisms of cell injury and death in hyperoxia: role of cytokines and Bcl-2 family proteins. Am. J. Respir. Cell Mol. Biol. 22 (2000) 517-519
18. Fox R.B., Hoidal J.R., Brown D.M., and Repine J.E. Pulmonary inflammation due to oxygen toxicity: involvement of chemotactic factors and polymorphonuclear leukocytes. Am. Rev. Respir. Dis. 123 (1981) 521-523
19. Raj J.U., Hazinski T.A., and Bland R.D. Oxygen-induced lung microvascular injury in neutropenic rabbits and lambs. J. Appl. Physiol. 58 (1985) 921-927
20. Chollet-Martin S., Jourdain B., Gibert C., Elbim C., Chastre J., and Gougerot-Pocidalo M.A. Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS. Am. J. Respir. Crit. Care Med. 154 (1996) 594-601
21. Goodman R.B., Strieter R.M., Martin D.P., Steinberg K.P., Milberg J.A., Maunder R.J., Kunkel S.L., Walz A., Hudson L.D., and Martin T.R. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 154 (1996) 602-611
22. Freeman B.A., Mason R.J., Williams M.C., and Crapo J.D. Antioxidant enzyme activity in alveolar type II cells after exposure of rats to hyperoxia. Exp. Lung Res. 10 (1986) 203-222
23. Crapo J.D., Hayatdavoudi G., Knapp M.J., Fracica P.J., Wolfe W.G., and Piantadosi C.A. Progressive alveolar septal injury in primates exposed to 60% oxygen for 14 days. Am. J. Physiol. 267 (1994) L797-L806
24. Olivera W.G., Ridge K.M., and Sznajder J.I. Lung liquid clearance and Na,K-ATPase during acute hyperoxia and recovery in rats. Am. J. Respir. Crit. Care Med. 152 (1995) 1229-1234
25. Barazzone C., Horowitz S., Donati Y.R., Rodriguez I., and Piguet P.F. Oxygen toxicity in mouse lung: pathways to cell death. Am. J. Respir. Cell Mol. Biol. 19 (1998) 573-581
26. Waxman A.B., Einarsson O., Seres T., Knickelbein R.G., Warshaw J.B., Johnston R., Homer R.J., and Elias J.A. Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation. J. Clin. Invest. 101 (1998) 1970-1982
27. Mantell L.L., Horowitz S., Davis J.M., and Kazzaz J.A. Hyperoxia-induced cell death in the lung-the correlation of apoptosis, necrosis, and inflammation. Ann. N. Y. Acad. Sci. 887 (1999) 171-180
28. Mantell L.L., and Lee P.J. Signal transduction pathways in hyperoxia-induced lung cell death. Mol. Genet. Metab. 71 (2000) 359-370
29. Kistler G.S., Caldwell P.R., and Weibel E.R. Development of fine structural damage to alveolar and capillary lining cells in oxygen-poisoned rat lungs. J. Cell Biol. 32 (1967) 605-628
30. Crapo J.D., Barry B.E., Foscue H.A., and Shelburne J. Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen. Am. Rev. Respir. Dis. 122 (1980) 123-143
31. Massaro D., and Massaro G.D. Biochemical and anatomical adaptation of the lung to oxygen-induced injury. Fed. Proc. 37 (1978) 2485-2488
32. Kazzaz J.A., Xu J., Palaia T.A., Mantell L., Fein A.M., and Horowitz S. Cellular oxygen toxicity. Oxidant injury without apoptosis. J. Biol. Chem. 271 (1996) 15182-15186
33. Jyonouchi H., Sun S., Abiru T., Chareancholvanich S., and Ingbar D.H. The effects of hyperoxic injury and antioxidant vitamins on death and proliferation of human small airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 19 (1998) 426-436
34. Mantell L.L., Kazzaz J.A., Xu J., Palaia T.A., Piedboeuf B., Hall S., Rhodes G.C., Niu G., Fein A.F., and Horowitz S. Unscheduled apoptosis during acute inflammatory lung injury. Cell Death Differ. 4 (1997) 600-607
35. Mantell L.L., Shaffer T.H., Horowitz S., Foust III R., Wolfson M.R., Cox C., Khullar P., Zakeri Z., Lin L., Kazzaz J.A., Palaia T., Scott W., and Davis J.M. Distinct patterns of apoptosis in the lung during liquid ventilation compared with gas ventilation. Am. J. Physiol. Lung Cell. Mol. Physiol. 283 (2002) L31-L41
36. Barazzone C., Donati Y.R., Rochat A.F., Vesin C., Kan C.D., Pache J.C., and Piguet P.F. Keratinocyte growth factor protects alveolar epithelium and endothelium from oxygen-induced injury in mice. Am. J. Pathol. 154 (1999) 1479-1487
37. Buckley S., Barsky L., Driscoll B., Weinberg K., Anderson K.D., and Warburton D. Apoptosis and DNA damage in type 2 alveolar epithelial cells cultured from hyperoxic rats. Am. J. Physiol. 274 (1998) L714-L720
38. Zhang X.F., and Foda H.D. [Pulmonary apoptosis and necrosis in hyperoxia-induced acute mouse lung injury]. Zhonghua Jie He He Hu Xi Za Zhi 27 (2004) 465-468
39. Tateda K., Deng J.C., Moore T.A., Newstead M.W., Paine III R., Kobayashi N., Yamaguchi K., and Standiford T.J. Hyperoxia mediates acute lung injury and increased lethality in murine Legionella pneumonia: the role of apoptosis. J. Immunol. 170 (2003) 4209-4216
40. Wang X., Ryter S.W., Dai C., Tang Z.L., Watkins S.C., Yin X.M., Song R., and Choi A.M. Necrotic cell death in response to oxidant stress involves the activation of the apoptogenic caspase-8/bid pathway. J. Biol. Chem. 278 (2003) 29184-29191
41. Crapo J.D. Morphologic changes in pulmonary oxygen toxicity. Annu. Rev. Physiol. 48 (1986) 721-731
42. Jyonouchi H., Sun S., Mizokami M., and Ingbar D.H. Cell density and antioxidant vitamins determine the effects of hyperoxia on proliferation and death of MDCK epithelial cells. Nutr. Cancer 28 (1997) 115-124
43. Kazzaz J.A., Horowitz S., Li Y., and Mantell L.L. Hyperoxia in cell culture. A non-apoptotic programmed cell death. Ann. N. Y. Acad. Sci. 887 (1999) 164-170
44. Gille J.J., Van Berkel C.G., and Joenje H. Mutagenicity of metabolic oxygen radicals in mammalian cell cultures. Carcinogenesis 15 (1994) 2695-2699
45. Franek W.R., Morrow D.M., Zhu H., Vancurova I., Miskolci V., Darley-Usmar K., Simms H.H., and Mantell L.L. NF-kappaB protects lung epithelium against hyperoxia-induced nonapoptotic cell death-oncosis. Free Radic. Biol. Med. 37 (2004) 1670-1679
46. Romashko III J., Horowitz S., Franek W.R., Palaia T., Miller E.J., Lin A., Birrer M.J., Scott W., and Mantell L.L. MAPK pathways mediate hyperoxia-induced oncotic cell death in lung epithelial cells. Free Radic. Biol. Med. 35 (2003) 978-993
47. De Paepe M.E., Mao Q., Chao Y., Powell J.L., Rubin L.P., and Sharma S. Hyperoxia-induced apoptosis and Fas/FasL expression in lung epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 289 (2005) L647-L659
48. Davis R.J. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268 (1993) 14553-14556
49. Li Y., Arita Y., Koo H.C., Davis J.M., and Kazzaz J.A. Inhibition of c-Jun N-terminal kinase pathway improves cell viability in response to oxidant injury. Am. J. Respir. Cell Mol. Biol. 29 (2003) 779-783
50. Morse D., Otterbein L.E., Watkins S., Alber S., Zhou Z., Flavell R.A., Davis R.J., and Choi A.M. Deficiency in the c-Jun NH2-terminal kinase signaling pathway confers susceptibility to hyperoxic lung injury in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 285 (2003) L250-L257
51. Petrache I., Choi M.E., Otterbein L.E., Chin B.Y., Mantell L.L., Horowitz S., and Choi A.M. Mitogen-activated protein kinase pathway mediates hyperoxia-induced apoptosis in cultured macrophage cells. Am. J. Physiol. 277 (1999) L589-L595
52. Buckley S., Driscoll B., Barsky L., Weinberg K., Anderson K., and Warburton D. ERK activation protects against DNA damage and apoptosis in hyperoxic rat AEC2. Am. J. Physiol. 277 (1999) L159-L166
53. Xu D., Guthrie J.R., Mabry S., Sack T.M., and Truog W.E. Mitochondrial aldehyde dehydrogenase attenuates hyperoxia-induced cell death through activation of ERK/MAPK and PI3K/Akt pathways in lung epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 291 (2006) L966-L975
54. Buckley S., Barsky L., Weinberg K., and Warburton D. In vivo inosine protects alveolar epithelial type 2 cells against hyperoxia-induced DNA damage through MAP kinase signaling. Am. J. Physiol. Lung Cell. Mol. Physiol. 288 (2005) L569-L575
55. 2-induced proliferation of primary alveolar epithelial cells is mediated by MAP kinases. Antioxid. Redox Signal. 7 (2005) 6-13
56. Lee P.J., and Choi A.M. Pathways of cell signaling in hyperoxia. Free Radic. Biol. Med. 35 (2003) 341-350
57. Otterbei L.E., Otterbein S.L., Ifedigbo E., Liu F., Morse D.E., Fearns C., Ulevitch R.J., Knickelbein R., Flavell R.A., and Choi A.M. MKK3 mitogen-activated protein kinase pathway mediates carbon monoxide-induced protection against oxidant-induced lung injury. Am. J. Pathol. 163 (2003) 2555-2563
58. O'reilly M.A., Staversky R.J., Huyck H.L., Watkins R.H., Lomonaco M.B., D'angio C.T., Baggs R.B., Maniscalco W.M., and Pryhuber G.S. Bcl-2 family gene expression during severe hyperoxia induced lung injury. Lab. Invest. 80 (2000) 1845-1854
59. Nyunoya T., Monick M.M., Powers L.S., Yarovinsky T.O., and Hunninghake G.W. Macrophages survive hyperoxia via prolonged ERK activation due to phosphatase down-regulation. J. Biol. Chem. 280 (2005) 26295-26302
60. Tilg H., Trehu E., Atkins M.B., Dinarello C.A., and Mier J.W. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83 (1994) 113-118
61. Xing Z., Gauldie J., Cox G., Baumann H., Jordana M., Lei X.F., and Achong M.K. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Invest. 101 (1998) 311-320
62. Waxman A.B., Mahboubi K., Knickelbein R.G., Mantell L.L., Manzo N., Pober J.S., and Elias J.A. Interleukin-11 and interleukin-6 protect cultured human endothelial cells from H2O2-induced cell death. Am. J. Respir. Cell Mol. Biol. 29 (2003) 513-522
63. Zhang X., Shan P., Qureshi S., Homer R., Medzhitov R., Noble P.W., and Lee P.J. Cutting edge: TLR4 deficiency confers susceptibility to lethal oxidant lung injury. J. Immunol. 175 (2005) 4834-4838
64. Torres M. Mitogen-activated protein kinase pathways in redox signaling. Front. Biosci. 8 (2003) d369-d391
65. Qureshi S.T., Zhang X., Aberg E., Bousette N., Giaid A., Shan P., Medzhitov R.M., and Lee P.J. Inducible activation of TLR4 confers resistance to hyperoxia-induced pulmonary apoptosis. J. Immunol. 176 (2006) 4950-4958
66. Truong S.V., Monick M.M., Yarovinsky T.O., Powers L.S., Nyunoya T., and Hunninghake G.W. Extracellular signal-regulated kinase activation delays hyperoxia-induced epithelial cell death in conditions of Akt downregulation. Am. J. Respir. Cell Mol. Biol. 31 (2004) 611-618
67. Chen Y.C., Chow J.M., Lin C.W., Wu C.Y., and Shen S.C. Baicalein inhibition of oxidative-stress-induced apoptosis via modulation of ERKs activation and induction of HO-1 gene expression in rat glioma cells C6. Toxicol. Appl. Pharmacol. 216 2 (2006) 263-273
68. Choi A.M., Sylvester S., Otterbein L., and Holbrook N.J. Molecular responses to hyperoxia in vivo: relationship to increased tolerance in aged rats. Am. J. Respir. Cell Mol. Biol. 13 (1995) 74-82
69. Beg A.A., and Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 274 (1996) 782-784
70. Franek W.R., Horowitz S., Stansberry L., Kazzaz J.A., Koo H.C., Li Y., Arita Y., Davis J.M., Mantell A.S., Scott W., and Mantell L.L. Hyperoxia inhibits oxidant-induced apoptosis in lung epithelial cells. J. Biol. Chem. 276 (2001) 569-575
71. Franek W.R., Chowdary Y.C., Lin X., Hu M., Miller E.J., Kazzaz J.A., Razzano P., Romashko III J., Davis J.M., Narula P., Horowitz S., Scott W., and Mantell L.L. Suppression of nuclear factor-kappa B activity by nitric oxide and hyperoxia in oxygen-resistant cells. J. Biol. Chem. 277 (2002) 42694-42700
72. Pepperl S., Dorger M., Ringel F., Kupatt C., and Krombach F. Hyperoxia upregulates the NO pathway in alveolar macrophages in vitro: role of AP-1 and NF-kappaB. Am. J. Physiol. Lung Cell. Mol. Physiol. 280 (2001) L905-L913
73. Schreck R., Albermann K., and Baeuerle P.A. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic. Res. Commun. 17 (1992) 221-237
74. Shea L.M., Beehler C., Schwartz M., Shenkar R., Tuder R., and Abraham E. Hyperoxia activates NF-kappaB and increases TNF-alpha and IFN-gamma gene expression in mouse pulmonary lymphocytes. J. Immunol. 157 (1996) 3902-3908
75. Parsey M.V., Kaneko D., Shenkar R., and Abraham E. Neutrophil apoptosis in the lung after hemorrhage or endotoxemia: apoptosis and migration are independent of interleukin-1beta. Chest 116 (1999) 67S-68S
76. Matute-Bello G., Liles W.C., Radella II F., Steinberg K.P., Ruzinski J.T., Jonas M., Chi E.Y., Hudson L.D., and Martin T.R. Neutrophil apoptosis in the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 156 (1997) 1969-1977
77. Suzuki Y., Nishio K., Takeshita K., Takeuchi O., Watanabe K., Sato N., Naoki K., Kudo H., Aoki T., and Yamaguchi K. Effect of steroid on hyperoxia-induced ICAM-1 expression in pulmonary endothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 278 (2000) L245-L252
78. Guthmann F., Wissel H., Schachtrup C., Tolle A., Rudiger M., Spener F., and Rustow B. Inhibition of TNFalpha in vivo prevents hyperoxia-mediated activation of caspase 3 in type II cells. Respir. Res. 6 (2005) 10
79. Barinaga M. Life-death balance within the cell. Science 274 (1996) 724
80. Dai Y., Pei X.Y., Rahmani M., Conrad D.H., Dent P., and Grant S. Interruption of the NF-kappaB pathway by Bay 11-7082 promotes UCN-01-mediated mitochondrial dysfunction and apoptosis in human multiple myeloma cells. Blood 103 (2004) 2761-2770
81. Wong H.R., Odoms K.K., Denenberg A.G., Allen G.L., and Shanley T.P. Hyperoxia prolongs tumor necrosis factor-alpha-mediated activation of NF-kappaB: role of IkappaB kinase. Shock 17 (2002) 274-279
82. Poynter M.E., Irvin C.G., and Janssen-Heininger Y.M. A prominent role for airway epithelial NF-kappa B activation in lipopolysaccharide-induced airway inflammation. J. Immunol. 170 (2003) 6257-6265
83. Cheng Q., Cant C.A., Moll T., Hofer-Warbinek R., Wagner E., Birnstiel M.L., Bach F.H., and De Martin R. NK-kappa B subunit-specific regulation of the I kappa B alpha promoter. J. Biol. Chem. 269 (1994) 13551-13557
84. Ito C.Y., Kazantsev A.G., and Baldwin Jr. A.S. Three NF-kappa B sites in the I kappa B-alpha promoter are required for induction of gene expression by TNF alpha. Nucleic Acids Res. 22 (1994) 3787-3792
85. Janssen-Heininger Y.M., Macara I., and Mossman B.T. Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-kappaB: requirement of Ras/mitogen-activated protein kinases in the activation of NF-kappaB by oxidants. Am. J. Respir. Cell Mol. Biol. 20 (1999) 942-952
86. Jornot L., and Junod A.F. Hyperoxia, unlike phorbol ester, induces glutathione peroxidase through a protein kinase C-independent mechanism. Biochem. J. 326 Pt 1 (1997) 117-123
87. Zafarullah M., Li W.Q., Sylvester J., and Ahmad M. Molecular mechanisms of N-acetylcysteine actions. Cell. Mol. Life Sci. 60 (2003) 6-20
88. Rahman I., Mulier B., Gilmour P.S., Watchorn T., Donaldson K., Jeffery P.K., and Macnee W. Oxidant-mediated lung epithelial cell tolerance: the role of intracellular glutathione and nuclear factor-kappaB. Biochem. Pharmacol. 62 (2001) 787-794
89. Choi H., Kim S.H., Chun Y.S., Cho Y.S., Park J.W., and Kim M.S. In vivo hyperoxic preconditioning prevents myocardial infarction by expressing bcl-2. Exp. Biol. Med (Maywood) 231 (2006) 463-472
90. Ward N.S., Waxman A.B., Homer R.J., Mantell L.L., Einarsson O., Du Y., and Elias J.A. Interleukin-6-induced protection in hyperoxic acute lung injury. Am. J. Respir. Cell Mol. Biol. 22 (2000) 535-542
91. Chen Q., Rabach L., Noble P., Zheng T., Lee C.G., Homer R.J., and Elias J.A. IL-11 receptor alpha in the pathogenesis of IL-13-induced inflammation and remodeling. J. Immunol. 174 (2005) 2305-2313
92. He C.H., Waxman A.B., Lee C.G., Link H., Rabach M.E., Ma B., Chen Q., Zhu Z., Zhong M., Nakayama K., Nakayama K.I., Homer R., and Elias J.A. Bcl-2-related protein A1 is an endogenous and cytokine-stimulated mediator of cytoprotection in hyperoxic acute lung injury. J. Clin. Invest. 115 (2005) 1039-1048
93. Quay J.L., Reed W., Samet J., and Devlin R.B. Air pollution particles induce IL-6 gene expression in human airway epithelial cells via NF-kappaB activation. Am. J. Respir. Cell Mol. Biol. 19 (1998) 98-106
94. Fehrenbach E., and Northoff H. Free radicals, exercise, apoptosis, and heat shock proteins. Exerc. Immunol. Rev. 7 (2001) 66-89
95. Karin M., Liu Z., and Zandi E. AP-1 function and regulation. Curr. Opin. Cell Biol. 9 (1997) 240-246
96. Shaulian E., and Karin M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4 (2002) E131-E136
97. Choi A.M., Pignolo R.J., Aprhys C.M., Cristofalo V.J., and Holbrook N.J. Alterations in the molecular response to DNA damage during cellular aging of cultured fibroblasts: reduced AP-1 activation and collagenase gene expression. J. Cell. Physiol. 164 (1995) 65-73
98. Darnell Jr. J.E. STATs and gene regulation. Science 277 (1997) 1630-1635
99. Lian X., Qin Y., Hossain S.A., Yang L., White A., Xu H., Shipley J.M., Li T., Senior R.M., Du H., and Yan C. Overexpression of Stat3C in pulmonary epithelium protects against hyperoxic lung injury. J. Immunol. 174 (2005) 7250-7256
100. Hokuto I., Ikegami M., Yoshida M., Takeda K., Akira S., Perl A.K., Hull W.M., Wert S.E., and Whitsett J.A. Stat-3 is required for pulmonary homeostasis during hyperoxia. J. Clin. Invest. 113 (2004) 28-37
101. Lee P.J., Alam J., Sylvester S.L., Inamdar N., Otterbein L., and Choi A.M. Overexpression of heme oxygenase-1 in human pulmonary epithelial cells result in cell growth arrest and increased resistance to hyperoxia. Proc. Natl. Acad. Sci. USA 93 19 (1996) 10393-10398
102. Lee P.J., Camhi S.L., Chin B.Y., Alam J., and Choi A.M. AP-1 and STAT mediate hyperoxia-induced gene transcription of heme oxygenase-1. Am. J. Physiol. Lung Cell. Mol. Physiol. 279 (2000) L175-L182
103. Cho H.Y., Jedlicka A.E., Reddy S.P., Kensler T.W., Yamamoto M., Zhang L.Y., and Kleeberger S.R. Role of NRF2 in protection against hyperoxic lung injury in mice. Am. J. Respir. Cell Mol. Biol. 26 (2002) 175-182
104. Cho H.Y., Jedlicka A.E., Reddy S.P., Zhang L.Y., Kensler T.W., and Kleeberger S.R. Linkage analysis of susceptibility to hyperoxia. Nrf2 is a candidate gene. Am. J. Respir. Cell Mol. Biol. 26 (2002) 42-51
105. Strassheim D., Asehnoune K., Park J.S., Kim J.Y., He Q., Richter D., Mitra S., Arcaroli J., Kuhn K., and Abraham E. Modulation of bone marrow-derived neutrophil signaling by H2O2: disparate effects on kinases, NF-kappaB, and cytokine expression. Am. J. Physiol. Cell Physiol. 286 (2004) C683-C692
106. Meyer C.F., Wang X., Chang C., Templeton D., and Tan T.H. Interaction between c-Rel and the mitogen-activated protein kinase kinase kinase 1 signaling cascade in mediating kappaB enhancer activation. J. Biol. Chem. 271 (1996) 8971-8976
107. Park J.H., and Levitt L. Overexpression of mitogen-activated protein kinase (ERK1) enhances T-cell cytokine gene expression: role of AP1, NF-AT, and NF-KB. Blood 82 (1993) 2470-2477
108. Kong A.N., Owuor E., Yu R., Hebbar V., Chen C., Hu R., and Mandlekar S. Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/EpRE). Drug Metab. Rev. 33 (2001) 255-271
109. Papaiahgari S., Kleeberger S.R., Cho H.Y., Kalvakolanu D.V., and Reddy S.P. NADPH oxidase and ERK signaling regulates hyperoxia-induced Nrf2-ARE transcriptional response in pulmonary epithelial cells. J. Biol. Chem. 279 (2004) 42302-42312
110. Auten R.L., Whorton M.H., and Nicholas Mason S. Blocking neutrophil influx reduces DNA damage in hyperoxia-exposed newborn rat lung. Am. J. Respir. Cell Mol. Biol. 26 (2002) 391-397
111. Rinaldo J.E., English D., Levine J., Stiller R., and Henson J. Increased intrapulmonary retention of radiolabeled neutrophils in early oxygen toxicity. Am. Rev. Respir. Dis. 137 (1988) 345-352
112. 2-exposed rabbits. J. Appl. Physiol. 61 (1986) 775-779
113. Christman J.W., Rinaldo J.E., Henson J.E., Moore S.A., and Dauber J.H. Modification by hyperoxia in vivo of endotoxin-induced neutrophil alveolitis in rats. Production of chemotactic factors by alveolar macrophages and ultrastructure. Am. Rev. Respir. Dis. 132 (1985) 152-158
114. D'angio C.T., Lomonaco M.B., Chaudhry S.A., Paxhia A., and Ryan R.M. Discordant pulmonary proinflammatory cytokine expression during acute hyperoxia in the newborn rabbit. Exp. Lung Res. 25 (1999) 443-465
115. Goodman R.B., Pugin J., Lee J.S., and Matthay M.A. Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev. 14 (2003) 523-535
116. Miller E.J., Cohen A.B., Nagao S., Griffith D., Maunder R.J., Martin T.R., Weiner-Kronish J.P., Sticherling M., Christophers E., and Matthay M.A. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am. Rev. Respir. Dis. 146 (1992) 427-432
117. Abul H., Abul A., Khan I., Mathew T.C., Ayed A., and Al-Athary E. Levels of IL-8 and myeloperoxidase in the lungs of pneumonia patients. Mol. Cell. Biochem. 217 (2001) 107-112
118. Deng H., Mason S.N., and Auten Jr. R.L. Lung inflammation in hyperoxia can be prevented by antichemokine treatment in newborn rats. Am. J. Respir. Crit. Care Med. 162 (2000) 2316-2323
119. Govindaraju V., Michoud M.C., Al-Chalabi M., Ferraro P., Powell W.S., and Martin J.G. Interleukin-8: novel roles in human airway smooth muscle cell contraction and migration. Am. J. Physiol. Cell Physiol. 291 (2006) C957-C965
120. Yi M., Jankov R.P., Belcastro R., Humes D., Copland I., Shek S., Sweezey N.B., Post M., Albertine K.H., Auten R.L., and Tanswell A.K. Opposing effects of 60% oxygen and neutrophil influx on alveologenesis in the neonatal rat. Am. J. Respir. Crit. Care Med. 170 (2004) 1188-1196
121. Sue R.D., Belperio J.A., Burdick M.D., Murray L.A., Xue Y.Y., Dy M.C., Kwon J.J., Keane M.P., and Strieter R.M. CXCR2 is critical to hyperoxia-induced lung injury. J. Immunol. 172 (2004) 3860-3868
122. Auten R.L., Richardson R.M., White J.R., Mason S.N., Vozzelli M.A., and Whorton M.H. Nonpeptide CXCR2 antagonist prevents neutrophil accumulation in hyperoxia-exposed newborn rats. J. Pharmacol. Exp. Ther. 299 (2001) 90-95
123. Auten Jr. R.L., Mason S.N., Tanaka D.T., Welty-Wolf K., and Whorton M.H. Anti-neutrophil chemokine preserves alveolar development in hyperoxia-exposed newborn rats. Am. J. Physiol. Lung Cell. Mol. Physiol. 281 (2001) L336-L344
124. Abraham E., Arcaroli J., Carmody A., Wang H., and Tracey K.J. HMG-1 as a mediator of acute lung inflammation. J. Immunol. 165 (2000) 2950-2954
125. Ulloa L., Batliwalla F.M., Andersson U., Gregersen P.K., and Tracey K.J. High mobility group box chromosomal protein 1 as a nuclear protein, cytokine, and potential therapeutic target in arthritis. Arthritis Rheum. 48 (2003) 876-881
126. Park J.S., Arcaroli J., Yum H.K., Yang H., Wang H., Yang K.Y., Choe K.H., Strassheim D., Pitts T.M., Tracey K.J., and Abraham E. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am. J. Physiol. Cell Physiol. 284 (2003) C870-C879
127. Ueno H., Matsuda T., Hashimoto S., Amaya F., Kitamura Y., Tanaka M., Kobayashi A., Maruyama I., Yamada S., Hasegawa N., Soejima J., Koh H., and Ishizaka A. Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am. J. Respir. Crit. Care Med. 170 (2004) 1310-1316
128. Lin X., Yang H., Sakuragi T., Hu M., Mantell L.L., Hayashi S., Al-Abed Y., Tracey K.J., Ulloa L., and Miller E.J. Alpha-chemokine receptor blockade reduces high mobility group box 1 protein-induced lung inflammation and injury and improves survival in sepsis. Am. J. Physiol. Lung Cell. Mol. Physiol. 289 (2005) L583-L590
129. Abraham E. What role does neutrophil apoptosis play in acute respiratory distress syndrome?. Crit. Care Med. 28 (2000) 253-254
130. Scaffidi P., Misteli T., and Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418 (2002) 191-195
131. Fiuza C., Bustin M., Talwar S., Tropea M., Gerstenberger E., Shelhamer J.H., and Suffredini A.F. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 101 (2003) 2652-2660
132. Javdan M., Wang H., Tracy K.J., Morrow D.M., Miller E.J., Sakuragi T., Hank H.H., and Mantell L.L. High mobility group box protein-1 (HMGB1) mediates hyperoxia induced proinflammatory lung injury. Proc. Am. Thoracic. Soc. 2 (2005) A90
133. Mantell L.L., Parrish W.R., and Ulloa L. Hmgb-1 as a therapeutic target for infectious and inflammatory disorders. Shock 25 (2006) 4-11
134. Rahman I., Gilmour P.S., Jimenez L.A., and Macnee W. Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation. Mol. Cell. Biochem. 234-235 (2002) 239-248
135. Abraham E. Neutrophils and acute lung injury. Crit. Care Med. 31 (2003) S195-S199
136. Baldwin Jr. A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14 (1996) 649-683
137. D'angio C.T., and Finkelstein J.N. Oxygen regulation of gene expression: a study in opposites. Mol. Genet. Metab. 71 (2000) 371-380
138. Shenkar R., and Abraham E. Hemorrhage induces rapid in vivo activation of CREB and NF-kappaB in murine intraparenchymal lung mononuclear cells. Am. J. Respir. Cell Mol. Biol. 16 (1997) 145-152
139. Moine P., Shenkar R., Kaneko D., Le Tulzo Y., and Abraham E. Systemic blood loss affects NF-kappa B regulatory mechanisms in the lungs. Am. J. Physiol. 273 (1997) L185-L192
140. Blackwell T.S., Blackwell T.R., Holden E.P., Christman B.W., and Christman J.W. In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. J. Immunol. 157 (1996) 1630-1637
141. Shenkar R., Schwartz M.D., Terada L.S., Repine J.E., Mccord J., and Abraham E. Hemorrhage activates NF-kappa B in murine lung mononuclear cells in vivo. Am. J. Physiol. 270 (1996) L729-L735
142. Kunsch C., Lang R.K., Rosen C.A., and Shannon M.F. Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL-6. J. Immunol. 153 (1994) 153-164
143. Barnes P.J., and Adcock I.M. Transcription factors and asthma. Eur. Respir. J. 12 (1998) 221-234
144. Collart M.A., Baeuerle P., and Vassalli P. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol. Cell. Biol. 10 (1990) 1498-1506
145. D'angio C.T., Lomonaco M.B., Johnston C.J., Reed C.K., and Finkelstein J.N. Differential roles for NF-kappa B in endotoxin and oxygen induction of interleukin-8 in the macrophage. Am. J. Physiol. Lung Cell. Mol. Physiol. 286 (2004) L30-L36
146. Allen G.L., Menendez I.Y., Ryan M.A., Mazor R.L., Wispe J.R., Fiedler M.A., and Wong H.R. Hyperoxia synergistically increases TNF-alpha-induced interleukin-8 gene expression in A549 cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 278 (2000) L253-L260
147. Odoms K., Shanley T.P., and Wong H.R. Short-term modulation of interleukin-1beta signaling by hyperoxia: uncoupling of IkappaB kinase activation and NF-kappaB-dependent gene expression. Am. J. Physiol. Lung Cell. Mol. Physiol. 286 (2004) L554-L562
148. Ulloa L., Ochani M., Yang H., Tanovic M., Halperin D., Yang R., Czura C.J., Fink M.P., and Tracey K.J. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc. Natl. Acad. Sci. USA 99 (2002) 12351-12356
149. Wang H., Liao H., Ochani M., Justiniani M., Lin X., Yang L., Al-Abed Y., Metz C., Miller E.J., Tracey K.J., and Ulloa L. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat. Med. 10 (2004) 1216-1221
150. Park J.S., Svetkauskaite D., He Q., Kim J.Y., Strassheim D., Shizaka A., and Abraham E. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279 (2004) 7370-7377
151. Yang G., Abate A.G., George A.G., Weng Y.H., and Dennery P.A. Maturational differences in lung NF-kappaB activation and their role in tolerance to hyperoxia. J. Clin. Invest. 114 (2004) 669-678